PRG S&Tech Inc. logo

PRG S&Tech Inc.

5 Marks
Corp.
First Filed:Nov 11, 2024Latest Filed:Nov 12, 2024Address:9F, 252 Geumjeong-ro, Geumjeong-gu, Busan, 46274, KR

Portfolio Overview

Registered
5(100%)

Top Classes

Class 5
Pharmaceuticals
5(100%)

TTAB Proceedings

No litigation activity

Top Firms

Revolution IP, PLLC(Nov 2024)
5

Trademark Portfolio

5 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
AGZYTO
AGZYTO
Trademark
Word
REGISTERED
Owner:
Serial:98848254
Filed:Nov 12, 2024
Classes:5
Registration:8082685
Registered:Dec 30, 2025
Goods & Services
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
ROZELCRA
ROZELCRA
Trademark
Word
REGISTERED
Owner:
Serial:98848260
Filed:Nov 12, 2024
Classes:5
Registration:8082686
Registered:Dec 30, 2025
Goods & Services
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
ZELRIBO
ZELRIBO
Trademark
Word
REGISTERED
Owner:
Serial:98848247
Filed:Nov 12, 2024
Classes:5
Registration:8082684
Registered:Dec 30, 2025
Goods & Services
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
ZELYBRO
ZELYBRO
Trademark
Word
REGISTERED
Owner:
Serial:98848239
Filed:Nov 12, 2024
Classes:5
Registration:8082683
Registered:Dec 30, 2025
Goods & Services
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
GERYDA
GERYDA
Trademark
Word
REGISTERED
Owner:
Serial:98847990
Filed:Nov 11, 2024
Classes:5
Registration:8082681
Registered:Dec 30, 2025
Goods & Services
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy